Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis

被引:0
作者
K Hussein
A Stucki-Koch
G Göhring
H Kreipe
M Suttorp
机构
[1] Institute of Pathology,Department of Pediatric Hematology and Oncology
[2] Hannover Medical School,undefined
[3] Institute of Human Genetics,undefined
[4] Hannover Medical School,undefined
[5] University Hospital Carl Gustav Carus,undefined
[6] TU Dresden,undefined
来源
Leukemia | 2017年 / 31卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Paediatric chronic myeloid leukaemia (ped-CML) is rare and ped-CML with fibre accumulation in the bone marrow (MF) is thought to be even rarer. In adults (ad-CML), fibrosis represents an adverse prognostic factor. So far, the pro-fibrotic changes in the bone marrow microenvironment have not been investigated in detail in ped-CML. From a total of 66 ped-CML in chronic phase, biopsies were analysable and 10 had MF1/2 (MF1, n=8/10; MF2, n=2/10). We randomly selected 16 ped-CML and 16 ad-CML cases with and without fibrosis (each n=8) as well as 18 non-neoplastic controls. Bone marrow samples were analysed with a real-time PCR-based assay (including 127 genes for paediatric cases) and by immunohistochemistry. We found increased expression of megakaryocytic genes in ped-CML. The number of megakaryocytes and pro-platelets are increased in CML patients, but the most significant increase was noted for ped-CML-MF1/2. Anti-fibrotic MMP9 expression was lower in children than in adults. Cell mobilisation-related CXCL12 was decreased in young and adult patients with CML but not the corresponding receptor CXCR4. In summary, fibre accumulation in ped-CML-MF1/2 is associated with increased megakaryocytic proliferation and increased interstitial pro-platelet deposition. Deregulated expression of matrix-modulating factors shifts the bone marrow microenvironment towards fibrosis.
引用
收藏
页码:1540 / 1546
页数:6
相关论文
共 268 条
  • [31] Catarsi P(2015)Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth Ann Clin Lab Sci 45 308-1027
  • [32] Kvasnicka HM(2011)Up-regulation of microRNA 146b is associated with myelofibrosis in myeloproliferative neoplasms Ann Hematol 90 307-268
  • [33] Beham-Schmid C(2012)Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia Curr Hematol Malig Rep 7 125-399
  • [34] Bob R(2015)Chronic myeloid leukemia stem cell biology Leuk Res 39 1020-192
  • [35] Dirnhofer S(2015)Bone marrow niche in the myelodysplastic syndromes Leukemia 29 259-1035
  • [36] Hussein K(2016)Myelodysplasia is in the niche: novel concepts and emerging therapies Blood 127 392-80
  • [37] Kreipe H(2015)Pediatric chronic myeloid leukemia is a unique disease that requires a different approach Ann Oncol 26 185-1738
  • [38] Eliacik E(2009)Differences among young adults, adults and elderly chronic myeloid leukemia patients Blood 114 342-400
  • [39] Isik A(2012)Chronic myeloid leukemia in pediatrics-first results from study CML-PAED II Haematologica 97 1029-40
  • [40] Aydin C(2014)Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy Ann Hematol 93 71-481